Hey, senior PhD students working on RNA and moving toward leading independent labs: Apply for the Maraganore Early Independence Fellow program at @UMassChan @RTI_UMassChan and come work with us! linkedin.com/posts/angelame…
Jon Watts
@jwattsgroup
Oligonucleotide Therapeutics and Chemical Biology. Find us also at @jwattsgroup.bsky.social
235 Following 937 Followers 410 Posts
Latest posts 5
Seems like they missed an opportunity here -- they could have called the combined company the Ornery Renegades... @orna_tx @ReNAgadeTx #RNA
ReNAgade Therapeutics is acquired by RNA rival Orna Therapeutics a year after launching with $300M. The combined startup will focus on in vivo CAR-T cells and an in vivo gene editing therapy for sickle cell disease. More details in my story for @endptsView quoted post on X
endpts.com/renagade-is-ac…
Congratulations to the newly minted Dr. @Samantha_Sarli for passing her thesis defense @RTI_UMassChan @UMassChan with a great defense talk.
In the latest paper from senior PhD student @Samantha_Sarli, we compare the activity profile of conjugated and unconjugated ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo. Amphiphilic lipids help drive safe uptake! Online now at NAR: academic.oup.com/nar/article/do…
Watts lab research was selected to compete in STAT Madness again this year! This time the featured research is our collaboration with Joel Richter's lab, building on their key insight that splice-switching ASOs may be therapeutic for Fragile X. Vote here: statnews.com/feature/stat-m…